Search clinical trials for: EZH2 Gain-of-function
Total 28 results
-
Fondazione Italiana Linfomi - ETSRecruiting
-
Chinese PLA General HospitalRecruitingLymphoma | Solid TumorChina
-
Epizyme, Inc.WEP ClinicalNo longer availableEpithelioid Sarcoma
-
Assiut UniversityRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & InstituteRecruitingRelapsed or Refractory Mature Lymphoid NeoplasmsChina
-
Vaishalee KenkreEpizyme, Inc.; University of Wisconsin, MadisonRecruitingFollicular LymphomaUnited States
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
PfizerRecruitingSmall Cell Lung Cancer (SCLC) | Follicular Lymphoma (FL) | Castration Resistant Prostate Cancer (CRPC)United States, Spain, Korea, Republic of, Poland, China, Bulgaria, Russian Federation, Japan
-
Epizyme, Inc.IpsenNot yet recruitingFollicular Lymphoma | Refractory Follicular Lymphoma
-
Constellation PharmaceuticalsActive, not recruitingMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Assiut UniversityUnknownAcute Myeloid Leukemia
-
Epizyme, Inc.CompletedMesothelioma | BAP1 Loss of FunctionUnited States, United Kingdom, France
-
Axter Therapeutics (Beijing) Co., LtdRecruitingRelapsed or Refractory Non-Hodgkin's LymphomaChina
-
Constellation PharmaceuticalsCompleted
-
Constellation PharmaceuticalsCompletedAdvanced Solid TumorsUnited States
-
Hutchison Medipharma LimitedRecruitingRelapsed/Refractory Follicular Lymphoma With EZH2China
-
VA Office of Research and DevelopmentVA Greater Los Angeles Healthcare SystemNot yet recruitingEZH2 Inhibitor, Tazemetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung CancerNon Small Cell Lung CancerUnited States
-
Evopoint Biosciences Inc.Merck Sharp & Dohme LLCRecruitingCarcinoma | Cervical Cancer | Prostate Cancer | Squamous Cell Carcinoma of Head and Neck | Non-small Cell Lung Cancer | Small-cell Lung Cancer | Urothelial Carcinoma | Other Solid TumorsChina
-
Novartis PharmaceuticalsActive, not recruitingDiffuse Large B-cell LymphomaSpain, Germany, Canada, Italy, Hong Kong, China, Japan, France, United States, Singapore
-
Eisai Co., Ltd.CompletedRelapsed or Refractory B-cell Non-Hodgkin's LymphomaJapan
-
Epizyme, Inc.CompletedSynovial Sarcoma | INI1-negative Tumors | Malignant Rhabdoid Tumor of Ovary | Rhabdoid TumorsUnited States, France, Canada, Italy, Germany, United Kingdom, Australia, Denmark, Netherlands
-
Eisai Co., Ltd.Recruiting
-
University of FloridaEpizyme, Inc.RecruitingPeripheral Nerve Sheath TumorUnited States
-
University of UtahTerminatedPrimary Myelofibrosis | Anemia | Thrombocytopenia | Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | IDH2 Gene Mutation | IDH1 Gene Mutation | Secondary Myelofibrosis | ASXL1 Gene Mutation | EZH2 Gene MutationUnited States
-
National Cancer Institute (NCI)Children's Oncology GroupActive, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Rhabdoid Tumor | Advanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Ann Arbor Stage III Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Recurrent Ependymoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent... and other conditionsUnited States, Puerto Rico
-
PfizerNot yet recruiting
-
Epizyme, Inc.CompletedSynovial Sarcoma | Epithelioid Sarcoma | Renal Medullary Carcinoma | Malignant Rhabdoid Tumors (MRT) | Rhabdoid Tumors of the Kidney (RTK) | Atypical Teratoid Rhabdoid Tumors (ATRT) | Selected Tumors With Rhabdoid Features | INI1-negative Tumors | Malignant Rhabdoid Tumor of Ovary | Poorly Differentiated... and other conditionsFrance, United States, Australia, Taiwan, Belgium, United Kingdom, Canada, Germany, Italy
-
Fudan UniversityRecruiting